MediWound (MDWD) Operating Income (2013 - 2026)
MediWound (MDWD) posted Operating Income of -$9.5 million for Q2 2026, down 18.52% on a QoQ basis from -$8.0 million in Q1 2026, and down 65.47% year-over-year from -$27.4 million in Q2 2025.
Analysis
MediWound (MDWD) Operating Income (2013 - 2026) Analysis & Trends
MediWound has reported Operating Income for 14 years, with the latest figure at -$9.5 million in Q2 2026.
- On a quarterly basis, Operating Income fell 65.47% year-over-year to -$9.5 million in Q2 2026; TTM through Jun 2026 was -$31.8 million, a 43.57% decrease from a year earlier, with the FY2025 full-year figure at -$25.3 million, down 30.24% from the prior year.
- Operating Income was -$9.5 million for Q2 2026 at MediWound, down from -$8.0 million in the prior quarter.
- The five-year high for Operating Income was $2.1 million in Q4 2022, with the low at -$9.5 million in Q2 2026.
- Average Operating Income over 5 years is -$4.8 million, with a median of -$4.4 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Operating Income surged 160.3% in 2022, then tumbled 283.42% in 2023.
- Over 5 years, Operating Income stood at $2.1 million in 2022, then sank by 283.42% to -$3.9 million in 2023, then slumped by 56.68% to -$6.1 million in 2024, then retreated by 27.85% to -$7.8 million in 2025, then declined by 21.26% to -$9.5 million in 2026.
- The last three Operating Income figures came in at -$9.5 million (Q2 2026), -$8.0 million (Q1 2026), and -$7.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -365.99 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | -9.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.46 Mn |
| Mar 31, 2026 | -7.98 Mn |
| Dec 31, 2025 | -7.80 Mn |
| Sep 30, 2025 | -6.53 Mn |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -5.23 Mn |
| Dec 31, 2024 | -6.10 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Jun 30, 2024 | -4.48 Mn |
| Mar 31, 2024 | -3.73 Mn |
| Dec 31, 2023 | -3.89 Mn |
| Sep 30, 2023 | -3.03 Mn |
| Jun 30, 2023 | -4.01 Mn |
| Mar 31, 2023 | -4.36 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Sep 30, 2022 | -3.51 Mn |
| Jun 30, 2022 | -3.67 Mn |
| Mar 31, 2022 | -3.28 Mn |
| Dec 31, 2021 | -3.52 Mn |
| Sep 30, 2021 | -2.88 Mn |